Latest Manufacturing News

Vitrafy Life Sciences reported a breakthrough 94.4% post-thaw platelet recovery in US Army Phase II testing, secured major US blood network partnerships, and raised $32 million to accelerate US expansion and device manufacturing.

Adherium Limited has posted a fourth consecutive quarter of record remote patient monitoring revenue, driven by growing device activations and strong clinical evidence from the iCARE study, positioning the company for expanded value-based care contracts in the US.

Australian Silica Quartz Group (ASQ) reports promising kaolin beneficiation results from its White Swan Project, with dry processing boosting kaolinite content to 83% and early ceramic tests confirming product quality. Chinese market feedback signals robust demand amid dwindling domestic supplies.

InteliCare generated positive cash flow for the first time since listing in the June 2026 quarter, driven by accelerated deployments across aged care and retirement living sectors.

West African Resources (ASX:WAF) delivered a record quarterly gold production of 125,179 ounces in Q2 2026, maintaining its trajectory toward full-year guidance amid robust cash generation and promising drilling results.

NeuroScientific Biopharmaceuticals achieved an 80% clinical response rate in fistulising Crohn’s disease patients treated under the TGA Special Access Scheme, advancing plans for Phase 2 trials and manufacturing scale-up.

Clean TeQ Water has commissioned its first full-scale PHOSPHIX® phosphate removal plant in Europe, surpassing regulatory and contractual standards and setting a commercial benchmark for future growth.

Firebird Metals has validated its proprietary Lithium Manganese Rich (LMR) cathode materials, achieving discharge capacities on par with commercial references and significantly surpassing conventional LFP and high-nickel NCM cathodes. This milestone underscores Firebird's integrated battery materials strategy and sets the stage for advanced optimisation at its Australian Demonstration Plant.

LTR Pharma’s SPONTAN shows rapid absorption in Phase II interim data while securing key US commercial deals for ROXUS, setting the stage for a US market entry later this year.

Element 25 is on track to commission its Butcherbird manganese expansion in early 2027, while securing a substantial US Department of Energy grant to support its US battery materials facility.

6K Additive surged to a record US$7.1 million revenue in Q2 2026, driven by strong demand in critical metal powders and backed by robust cash reserves and government contracts.

Tivan Limited has locked in key investment frameworks worth up to $50 million for its Molyhil Tungsten Project and confirmed premium acidgrade fluorspar production at Speewah, underpinning strong project economics and strategic partnerships.